Trial · NCT00460564
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Phase (12 Weeks) | STARTED | High-Dose BTX | 51 | |
| Double-Blind Phase (12 Weeks) | STARTED | High-Dose Placebo | 26 | |
| Double-Blind Phase (12 Weeks) | STARTED | Low-Dose BTX | 21 | |
| Double-Blind Phase (12 Weeks) | STARTED | Low-Dose Placebo | 11 | |
| Double-Blind Phase (12 Weeks) | STARTED | DB High-Dose BTX + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | STARTED | DB High-Dose Placebo + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | STARTED | DB Low-Dose BTX + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | STARTED | DB Low-Dose Placebo + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | High-Dose BTX | 47 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | High-Dose Placebo | 25 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | Low-Dose BTX | 21 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | Low-Dose Placebo | 11 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | DB High-Dose BTX + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | DB High-Dose Placebo + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | DB Low-Dose BTX + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | COMPLETED | DB Low-Dose Placebo + OL High-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | NOT COMPLETED | High-Dose BTX | 4 | |
| Double-Blind Phase (12 Weeks) | NOT COMPLETED | High-Dose Placebo | 1 | |
| Double-Blind Phase (12 Weeks) | NOT COMPLETED | Low-Dose BTX | 0 | |
| Double-Blind Phase (12 Weeks) | NOT COMPLETED | Low-Dose Placebo | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00460564/flow